Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1Gastrointestinal 1

Conditions

Barrett Esophagus 2Zollinger-Ellison Syndrome 1Xerostomia 1Stomach Ulcer 1Oropharyngeal Neoplasms 1Mucositis 1Inflammation 1Heartburn 1Head and Neck Neoplasms 1Gastroesophageal Reflux 1Esophagitis, Peptic 1

Interventions

Endoscopy, Digestive System 4Esomeprazole 3Biopsy 3YF 476 2Specimen Handling 2Proton Pump Inhibitors 2Lansoprazole 2Endoscopy 2plecanatide 1omeprazole, sodium bicarbonate drug combination 1linaclotide 1ilaprazole 1Surveys and Questionnaires 1Rabeprazole 1Proflavine 1Lysine Acetyltransferase 5 1Gastropexy 1Gastroenterostomy 1Gastric Bypass 1Fundoplication 1Fluorescein 1Endoscopic Mucosal Resection 1Endoscopes 1Diet, Gluten-Free 1Dexlansoprazole 1Anastomosis, Roux-en-Y 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Gastroesophageal Reflux × Dexlansoprazole × Clear all
NCT00928161 2012-09-07

Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy

M.D. Anderson Cancer Center

Phase NA Withdrawn
GastrointestinalHead & NeckOther

Gastroesophageal Reflux, Head and Neck Neoplasms, Heartburn, Oropharyngeal Neoplasms, Xerostomia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡